Intraventricular immunovirotherapy; a translational step forward
Oncotarget · 2023
DOI: 10.18632/oncotarget.28343 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, 2023. Verfasst von Joshua D Bernstock und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Oncolytic Viruses, Oncolytic Virotherapy, Glioma, Cerebellar Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Oncolytic virotherapy with intratumoral engineered type-1 herpes simplex virus (HSV) has been proven safe with promising efficacy in recent clinical trials for treatment of both pediatric and adult high-grade glioma. However, this approach excludes patients with tumors in surgically inaccessible and/or eloquent brain regions. Current delivery methods are also unable to access/treat those patients with metastatic disease in the spinal cord and/or leptomeningeal disease. A recent preclinical study has paved the way for clinical translation of intraventricular administration of oHSV by identifying and mitigating the toxicity associated with this route for therapeutic benefit in murine models of disseminated medulloblastoma. This work may ultimately allow for targeting of intractable disease and provides a feasible option for the repetitive dosing of clinically relevant immunovirotherapy, G207.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
- Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL 35233, USA.
Zitieren
APA
Bernstock, J. D., Blitz, S., Kang, K. D., & Friedman, G. K. (2023). Intraventricular immunovirotherapy; a translational step forward. Oncotarget. https://doi.org/10.18632/oncotarget.28343
Vancouver
Bernstock JD, Blitz S, Kang KD, Friedman GK. Intraventricular immunovirotherapy; a translational step forward. Oncotarget. 2023. doi:10.18632/oncotarget.28343
BibTeX
@article{Bernstock2023,
author = {Bernstock, Joshua D and Blitz, Sarah and Kang, Kyung-Don and Friedman, Gregory K},
title = {Intraventricular immunovirotherapy; a translational step forward},
journal = {Oncotarget},
year = {2023},
doi = {10.18632/oncotarget.28343}
}
EUVIMED